# AbbVie Clinical Pharmacology Research Unit (ACPRU) – FDA Inspection, Jan 10, 2020

Source: https://www.keypedia.com/records/fda_inspections/abbvie-clinical-pharmacology-research-unit-acpru/21107ff7-956e-405e-b70f-3b8cb6da31e3
Source feed: FDA_Inspections

> FDA inspection 1117577 of AbbVie Clinical Pharmacology Research Unit (ACPRU), January 10, 2020. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117577
- Company Name: AbbVie Clinical Pharmacology Research Unit (ACPRU)
- Inspection Date: 2020-01-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1036929 - 2017-12-01

Company: https://www.keypedia.com/companies/abbvie-clinical-pharmacology-research-unit-acpru/becf4a4a-6a00-4262-ace6-43a8e7a50381

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c